COMMUNIQUÉS West-GlobeNewswire

Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim
20/03/2019
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the U.S. Food & Drug [...]
Herantis Pharma’s Annual Report 2018 published
20/03/2019
Herantis Pharma’s Annual Report 2018 published Herantis Pharma Plc Company release 20 March 2019 at 9:00 am Herantis Pharma Plc’s Annual Report for the year 2018 has been published today. The Annual Report contains [...]
2018 financial results and business update: landmark deal with AstraZeneca to support transition into a fully integrated oncology-focused biotech, strong clinical progress in lead assets
20/03/2019
2018 FINANCIAL RESULTS AND BUSINESS UPDATE: LANDMARK DEAL WITH ASTRAZENECA TO SUPPORT TRANSITION INTO A FULLY INTEGRATED ONCOLOGY-FOCUSED BIOTECH, STRONG CLINICAL PROGRESS IN LEAD ASSETS Cash, cash equivalents and [...]
Resultats annuels 2018 : accord majeur avec AstraZeneca appuyant la transition vers une societe de biotechnologies integree et donnees prometteuses pour les programmes principaux
20/03/2019
La trésorerie, équivalents de trésorerie et actifs financiers [*] s’élèvent à 202,7m€ (millions d’euros) au 31 décembre 2018 (176,6m€ en 2017) Les produits opérationnels s’élèvent à 94,0m€ (36,2m€ en 2017) Les charges [...]
Dermira Prices $130.0 Million Public Offering of Common Stock
20/03/2019
MENLO PARK, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
resTORbio, Inc. Announces Pricing of Public Offering of Common Stock
20/03/2019
BOSTON, March 19, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (“resTORbio” or the “Company”) (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to [...]
Abeona Therapeutics annonce ses résultats financiers du quatrième trimestre et de l’exercice complet 2018
19/03/2019
En voie de lancer l'essai clinique VITAL™ de Phase 3 pour le traitement de la RDEB au milieu de 2019 ; EB-101 sera fabriqué en interne Fabrication à l'échelle pour supporter les programmes basés sur AAV ; préparation [...]
Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced
19/03/2019
Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced Mihir Shah of UE LifeSciences Inc. has been selected as the winner of the 2019 Lyfebulb-Helsinn Innovation Award in [...]
Oasmia Pharmaceutical AB (publ): Press release from the extraordinary general meeting 19 March 2019
19/03/2019
In Oasmia Pharmaceutical AB (publ) (“Oasmia” or the ”Company”) an extraordinary general meeting was held today. The extraordinary general meeting was convened at the request of shareholders representing more than 10 per [...]
DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update
19/03/2019
Dosed first patients in Phase Ib study of DM199 in Chronic Kidney Disease patients under an IND accepted by the FDA in 2018; Plan to initiate Phase II studies in 2H 2019 Acute ischemic stroke Phase II REMEDY clinical [...]
Rubius Therapeutics to Announce Fourth Quarter and Full-Year 2018 Financial Results
19/03/2019
CAMBRIDGE, Mass., March 19, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new [...]
Principia Biopharma Reports Fourth Quarter and Full Year 2018 Financial Results
19/03/2019
SOUTH SAN FRANCISCO, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Maple Leaf Enters into a Consulting Agreement with DHC B.V.
19/03/2019
CALGARY, Alberta, March 19, 2019 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) announces that the Company has entered into a consulting agreement (the “ [...]
Teligent, Inc. Announces FDA Approval of Fluocinonide Topical Solution USP, 0.05%
19/03/2019
BUENA, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
SuperSonic Imagine provides the Paris Radiology Institute with 11 Aixplorer MACH® 30 ultrasound systems
19/03/2019
Aixplorer systems currently used in the senology department are being replaced with the new Aixplorer MACH® 30 platform Two additional Aixplorer MACH 30 devices for general imaging AIX-EN-PROVENCE, France, March 19, [...]
William Demant Holding A/S: Decisions of annual general meeting 2019
19/03/2019
Company announcement no 2019-04 19 March 2019 Annual general meeting Today, William Demant Holding A/S held its annual general meeting at the Company’s premises, Kongebakken 9, 2765 Smørum, Denmark. All proposals put [...]
Axim® Biotechnologies Receives New U.S. Patent Issuance for Topical Cream Containing Cannabinoids
19/03/2019
NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the issuance of a Notice of [...]
PROJECT HOPE PREPARES RESPONSE TO DEADLY MOZAMBIQUE CYCLONE
19/03/2019
Millions of people impacted; more than 1,000 lives feared lost Millwood, Virginia, March 19, 2019 (GLOBE NEWSWIRE) -- Project HOPE is on the ground in Mozambique assessing the immediate needs of thousands of women, [...]
UPDATE - Arch Biopartners Receives Approval to Perform Phase I Clinical Trial for Metablok in Australia
19/03/2019
TORONTO, March 19, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), today announced that it has been granted approval by the Alfred Hospital Ethics [...]

Pages